Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Electron microscopy studies of the bactericidal effects of quinupristin/dalfopristin on Staphylococcus aureus.

Lorian V, Fernandes F.

J Antimicrob Chemother. 1999 Jun;43(6):845. No abstract available.

PMID:
10404327
2.
3.

Susceptibility of vancomycin-resistant enterococci to environmental disinfectants.

Lorian V, Fernandes F.

Infect Control Hosp Epidemiol. 1997 Oct;18(10):678-9. No abstract available.

PMID:
9350456
4.

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C.

Clin Infect Dis. 1997 Sep;25(3):584-99. Review.

PMID:
9314444
5.

The effect of vancomycin on the structure of vancomycin-susceptible and -resistant Enterococcus faecium strains.

Lorian V, Fernandes F.

Antimicrob Agents Chemother. 1997 Jun;41(6):1410-1. No abstract available.

6.

Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium.

Lorian V, Fernandes F.

J Antimicrob Chemother. 1997 May;39 Suppl A:63-6.

PMID:
9511065
7.

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C.

Infect Control Hosp Epidemiol. 1997 Apr;18(4):275-91.

PMID:
9131374
8.

Trends in the prevalence of methicillin-resistant Staphylococcus aureus associated with discontinuation of an isolation policy.

Fazal BA, Telzak EE, Blum S, Turett GS, Petersen-Fitzpatrick FE, Lorian V.

Infect Control Hosp Epidemiol. 1996 Jun;17(6):372-4.

PMID:
8805071
9.

The need for surveillance for antimicrobial resistance.

Lorian V.

Infect Control Hosp Epidemiol. 1995 Nov;16(11):638-41.

PMID:
8601684
10.

Oral ciprofloxacin vs intravenous therapy with nonquinolone agents. A study of 291 infections.

Lorian V, Pavletich K.

Drugs. 1995;49 Suppl 2:477-9. No abstract available.

PMID:
8549406
11.

RP 59500 postantibiotic effect defined by bacterial ultrastructure.

Lorian V, Amaral L, Fernandes F.

Drugs Exp Clin Res. 1995;21(3):125-8.

PMID:
7555615
12.

Colonization resistance.

Lorian V.

Antimicrob Agents Chemother. 1994 Jul;38(7):1693. No abstract available.

13.

Ultrastructure alterations of Staphylococcus aureus exposed to RP59500.

Lorian V, Esanu Y, Amaral L.

J Antimicrob Chemother. 1994 Mar;33(3):625-8. No abstract available.

PMID:
8040126
14.
15.

Medical relevance of low concentrations of antibiotics.

Lorian V.

J Antimicrob Chemother. 1993 May;31 Suppl D:137-48. Review.

PMID:
8335515
16.

Synergic effect of chlorpromazine on the activity of some antibiotics.

Amaral L, Kristiansen J, Lorian V.

J Antimicrob Chemother. 1992 Oct;30(4):556-8. No abstract available.

PMID:
1490927
17.

Predictive value of blood cultures.

Lorian V, Amaral L.

Infect Control Hosp Epidemiol. 1992 May;13(5):293-4. No abstract available. Erratum in: Infect Control Hosp Epidemiol 1992 Dec;13(12):693.

PMID:
1302459
18.

Effects of chlorpromazine on the cell envelope proteins of Escherichia coli.

Amaral L, Lorian V.

Antimicrob Agents Chemother. 1991 Sep;35(9):1923-4.

19.

Predictive value of susceptibility tests for the outcome of antibacterial therapy.

Lorian V, Burns L.

J Antimicrob Chemother. 1990 Jan;25(1):175-81.

PMID:
2318750
20.

Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections.

Menon L, Ernst JA, Sy ER, Flores D, Pacia A, Lorian V.

Am J Med. 1989 Nov 30;87(5A):119S-120S. No abstract available.

PMID:
2686412
21.

In vitro simulation of in vivo conditions: physical state of the culture medium.

Lorian V.

J Clin Microbiol. 1989 Nov;27(11):2403-6. Review. No abstract available.

22.

The post-antibiotic effect defined by bacterial morphology.

Lorian V, Ernst J, Amaral L.

J Antimicrob Chemother. 1989 Apr;23(4):485-91.

PMID:
2663811
23.

Activity of amikacin and ampicillin in succession and in combination.

Lorian V, Ernst J.

Diagn Microbiol Infect Dis. 1988 Nov;11(3):163-9.

PMID:
3149928
24.

Differences between in vitro and in vivo studies.

Lorian V.

Antimicrob Agents Chemother. 1988 Oct;32(10):1600-1. No abstract available.

25.

The third K. Prathap memorial lecture. Effects of antibiotics on bacterial pathogenicity.

Lorian V, Ernst J.

Malays J Pathol. 1988 Aug;10:21-31. No abstract available.

PMID:
3252074
26.

AIDS, anal sex, and heterosexuals.

Lorian V.

Lancet. 1988 May 14;1(8594):1111. No abstract available.

PMID:
2896941
27.

Effects of antibiotics on bacterial structure and their pathogenicity.

Lorian V, Ernst J.

Pathol Biol (Paris). 1987 Dec;35(10 Pt 2):1370-6. Review.

PMID:
3325898
28.

Bacterial resistance to antibiotics in the United States. Ten million strains, nine species and sixteen antibiotics.

Lorian V, Atkinson B.

Drugs Exp Clin Res. 1987;13(8):457-77. No abstract available.

PMID:
3428129
29.

Penicillin-binding site on the Escherichia coli cell envelope.

Amaral L, Lee Y, Schwarz U, Lorian V.

J Bacteriol. 1986 Aug;167(2):492-5.

30.

Amikacin-induced alterations in the structure of gram-negative bacilli.

Lorian V, Atkinson BA.

Diagn Microbiol Infect Dis. 1986 Jul;5(2):93-7.

PMID:
3522089
31.

Ciprofloxacin in the treatment of pneumonia.

Ernst JA, Sy ER, Colon-Lucca H, Sandhu N, Rallos T, Lorian V.

Antimicrob Agents Chemother. 1986 Jun;29(6):1088-9.

32.
34.

Staphylococci, in vitro and in vivo.

Lorian V, Zak O, Suter J, Bruecher C.

Diagn Microbiol Infect Dis. 1985 Sep;3(5):433-44.

PMID:
4028668
35.

Phagocytosis of staphylococci after exposure to antibiotics, mass versus colony-forming units.

Lorian V.

J Antimicrob Chemother. 1985 Jul;16(1):130-2. No abstract available.

PMID:
4044464
36.

Bacterial resistance to antibiotics in American hospitals.

Lorian V, Gardner DA.

Chemioterapia. 1985 Feb;4(1):14-8.

PMID:
3986941
37.

Antibacterial activity in blood cultures.

Rodriguez F, Lorian V.

J Clin Microbiol. 1985 Feb;21(2):262-3.

38.

Low concentrations of antibiotics.

Lorian V.

J Antimicrob Chemother. 1985 Jan;15 Suppl A:15-26.

PMID:
3980327
39.

Effect of pH on the morphology of Staphylococcus aureus.

Mirza J, Kim Y, Lorian V.

Drugs Exp Clin Res. 1985;11(3):149-53.

PMID:
3915285
40.

Ultrastructure of staphylococci in respiratory infections treated with nafcillin.

Ernst J, Sy E, Lorian V, Kim Y.

Drugs Exp Clin Res. 1985;11(6):357-60.

PMID:
3836133
41.
42.

Speciation polemic.

Lorian V, Louria DB.

J Infect Dis. 1984 May;149(5):661-2. No abstract available.

PMID:
6726001
43.
44.

Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin.

Lorian V, Zak O, Kunz S, Vaxelaire J.

Antimicrob Agents Chemother. 1984 Mar;25(3):311-5.

45.

Single-dose amoxicillin therapy with follow-up urine culture.

Ben Redjeb S, Slim A, Horchani A, Zmerli S, Boujnah A, Lorian V.

Am J Med. 1984 Mar;76(3):A79, A87. No abstract available.

PMID:
6702868
46.

Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.

Lorian V, Atkinson B, Kim Y.

Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S418-27.

PMID:
6556709
47.

Phagocytosis of filaments of Escherichia coli produced with mezlocillin.

Lorian V, Atkinson B, Kim Y.

J Antimicrob Chemother. 1983 May;11 Suppl C:71-8.

PMID:
6352607
48.

Effects of ten milligrams of ampicillin per day on urinary tract infections.

Redjeb SB, Slim A, Horchani A, Zmerilli S, Boujnah A, Lorian V.

Antimicrob Agents Chemother. 1982 Dec;22(6):1084-6.

49.

Abnormal morphology of bacteria in the sputa of patients treated with antibiotics.

Lorian V, Waluschka A, Kim Y.

J Clin Microbiol. 1982 Aug;16(2):382-6.

50.

Determination of the range of antibacterial activity by use of viable counts.

Lorian V, Atkinson BA.

J Clin Microbiol. 1982 Jul;16(1):70-6.

Supplemental Content

Loading ...
Support Center